ANGELA WHITE: Open Payments
NPI 1659829240 · LAWRENCEBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 55 payments from 20 companies in 2025. Trend: 2023 $752 · 2024 $899 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $86 |
| Lilly USA, LLC | 5 | $86 |
| PFIZER INC. | 5 | $80 |
| AstraZeneca Pharmaceuticals LP | 5 | $74 |
| Corium, LLC | 4 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Novo Nordisk Inc | 3 | $46 |
| Esperion Therapeutics, Inc. | 3 | $45 |
| Astellas Pharma US Inc | 2 | $43 |
Products named: CAPLYTA, ELIQUIS, MOUNJARO, Azstarys, Jornay PM, JARDIANCE, UBRELVY, QULIPTA.
Industry payments across IN — which companies pay providers there.
